I have talked about diabetes before – both in terms of technology and cost – but every day it seems to be a greater topic of discussion and research. According to the Centers of Disease Control and Prevention, it is now the seventh leading cause of death, affecting 29 million Americans.
The MIT news office recently wrote an article about Common Sensing’s plan to solve the nation’s diabetes-management issues by going digital. Common Sensing is a startup, founded by MIT students in 2012 and based in Cambridge, MA, that creates hardware and software medical device solutions for diabetes care. Their first product, called the Gocap, is a Bluetooth connected pen cap for injector pens that automatically track insulin doses as well as other dose-related information.
More accurately, Rob Matheson wrote:
“The startup’s smart insulin-pen cap logs insulin intake data on an app and in the cloud, to help patients better manage their regimen. Moreover, the cap gives doctors a detailed view into patients’ insulin habits and how they affect blood-glucose levels, for more targeted care.”
Right now, the Gocap is going through clinical studies in order to test it out. The co-founders James White and Richard Whalley have partnered with Joslin Diabetes Center in Boston to collect data on 125 patients using the cap over the course of the next year.
The product isn’t available yet but when it is it will be accessible to insurers, pharmaceutical companies, and clinicians. The end goal is to have them be free of charge to the people who need them.